News resources
| Wal-Mart Stores Inc (WMT) | 44 stories... |
| Google Inc (GOOG) | 42 stories... |
| Citigroup Inc (C) | 38 stories... |
| Bank of America Corp (BAC) | 36 stories... |
| Amazon.com Inc (AMZN) | 35 stories... |
| advertisement |
Incyte Corp: All Recent News
- 10 Stocks Shaking the Market 8:58 AM
- These stocks have been looking up over the past month. At Motley Fool
- Incyte 3Q loss narrows on lower costs 11/5/2009
- WILMINGTON, Del. (AP) - Biotechnology company Incyte Corp. said Thursday its third-quarter loss narrowed on lower costs as it prioritized is pipeline of potential products. Associated Press
- Incyte Reports Third Quarter 2009 Financial Results and... 11/5/2009
- Incyte Corporation (Nasdaq:INCY) today reported third quarter 2009 financial results and provided an update on its lead programs. Paul A. Friedman, M.D., Incyte's President and Chief Executive... Business Wire
- Trading Outlook for Incyte Corp. Issued by StockPreacher.com 10/28/2009
- DALLAS, Oct. 28, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring biopharmaceutical company Incyte Corp. (Nasdaq:INCY). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision. GlobeNewswire
- Incyte to Report Third Quarter 2009 Financial Results and... 10/20/2009
- Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its third quarter 2009 financial results conference call for 8:30 a.m. ET on Thursday, November 5, 2009. The schedules for the... Business Wire
- Incyte to Present at the Fourth Annual JMP Securities... 9/30/2009
- Incyte Corporation (Nasdaq:INCY) announced today it will present at the Fourth Annual JMP Securities Healthcare Focus Conference on Monday, October 5, 2009 at 10:30 a.m. ET. Presenting for Incyte... Business Wire
- Incyte Completes Offering of Convertible Senior Notes 9/30/2009
- Incyte Corporation (Nasdaq:INCY) today announced that it has completed its previously announced private placement of $400.0 million aggregate principal amount of 4.75% Convertible Senior Notes due... Business Wire
- Incyte Announces Closing of Public Offering of Common Stock 9/30/2009
- Incyte Corporation (Nasdaq:INCY) today announced the closing of its public offering of 20,700,000 shares of its common stock at a price to the public of $6.75 per share, which includes 2,700,000... Business Wire
- Incyte Prices $350 Million Convertible Senior Notes Offering 9/24/2009
- Incyte Corporation (Nasdaq: INCY) today announced the pricing of its offering of $350 million aggregate principal amount of 4.75% Convertible Senior Notes due 2015 in a private placement to... Business Wire
- Incyte Announces Pricing of Public Offering of 18,000,000... 9/24/2009
- Incyte Corporation (Nasdaq:INCY) today announced the pricing of its underwritten public offering of 18,000,000 shares of its common stock at a price to the public of $6.75 per share. The offering is... Business Wire
- Incyte Announces Proposed Offering of $250 Million Convertible... 9/22/2009
- Incyte Corporation (Nasdaq:INCY) today announced that it intends to offer, subject to market and other conditions, up to $250 million aggregate principal amount of Convertible Senior Notes due 2015... Business Wire
- Incyte Announces Proposed Public Offering of 18,000,000 Shares... 9/22/2009
- Incyte Corporation (Nasdaq:INCY) today announced that it intends to offer to sell, subject to market and other conditions, 18,000,000 shares of its common stock in an underwritten public offering. Business Wire
- Market Report -- Story Stocks (INCY) 9/21/2009
- Incyte Incyte (INCY 7.95, +0.66) announced positive top-line Phase IIb results this morning for Topical INCB18424 in Psoriasis. The company said these results were obtained from a... Briefing.com
- Incyte Announces Positive Top-Line Phase IIb Results for... 9/21/2009
- Incyte Corporation (Nasdaq:INCY) announced positive clinical trial results for a topical formulation of its lead janus kinase (JAK) inhibitor, INCB18424, in psoriasis. These results were obtained... Business Wire
- Incyte to Present at Upcoming Investor Conferences 9/3/2009
- Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences: Baird 2009 Health Care Conference on Wednesday, September 9, 2009 at 10:00 a.m. (ET) in New... Business Wire
- More News
- Market Report
- News by Symbol
- Today's Investing Articles
- Breaking News
- News by Topic
- News by Industry
- MSNBC News
- Data providers
- Copyright © 2009 Thomson Reuters. Click for Restrictions.
- Quotes supplied by Interactive Data Real-Time Services.

